[Federal Register Volume 84, Number 168 (Thursday, August 29, 2019)]
[Notices]
[Page 45475]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-18633]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary

[Docket ID DoD-2019-HA-0065]


Submission for OMB Review; Comment Request

AGENCY: Office of the Assistant Secretary of Defense for Health 
Affairs, DoD.

ACTION: 30-Day information collection notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Defense has submitted to OMB for clearance 
the following proposal for collection of information under the 
provisions of the Paperwork Reduction Act.

DATES: Consideration will be given to all comments received by 
September 30, 2019.

ADDRESSES: Comments and recommendations on the proposed information 
collection should be emailed to Mr. Josh Brammer, DoD Desk Officer, at 
[email protected]. Please identify the proposed information 
collection by DoD Desk Officer, Docket ID number, and title of the 
information collection.

FOR FURTHER INFORMATION CONTACT: Angela James, 571-372-7574, or [email protected].

SUPPLEMENTARY INFORMATION: 
    Title; Associated Form; and OMB Number: Federal Agency Retail 
Pharmacy Program; OMB Control Number 0720-0032.
    Type of Request: Extension
    Number of Respondents: 300.
    Responses per Respondent: 4.
    Annual Responses: 1,200.
    Average Burden per Response: 8 hours.
    Annual Burden Hours: 9,600.
    Needs and Uses: The information collection requirement is necessary 
to obtain and record refund amounts between the DoD and pharmaceutical 
manufacturers. The DoD quarterly provides pharmaceutical manufacturers 
with itemized utilization data on covered drugs dispensed to TRICARE 
beneficiaries through TRICARE retail network pharmacies. These 
manufacturers validate the refund amounts calculated from the 
difference in price between the Federal Ceiling Prices and the direct 
commercial contract sales price. Once the refund amounts are validated, 
the pharmaceutical manufacturers directly pay the DHA Government 
account.
    Affected Public: Business or other for-profit.
    Frequency: Quarterly.
    Respondent's Obligation: Voluntary.
    OMB Desk Officer: Mr. Josh Brammer.
    You may also submit comments and recommendations, identified by 
Docket ID number and title, by the following method:
     Federal eRulemaking Portal: http://www.regulations.gov. 
Follow the instructions for submitting comments.
    Instructions: All submissions received must include the agency 
name, Docket ID number, and title for this Federal Register document. 
The general policy for comments and other submissions from members of 
the public is to make these submissions available for public viewing on 
the internet at http://www.regulations.gov as they are received without 
change, including any personal identifiers or contact information.
    DOD Clearance Officer: Ms. Angela James.
    Requests for copies of the information collection proposal should 
be sent to Ms. James at [email protected].

    Dated: August 23, 2019.
Aaron T. Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2019-18633 Filed 8-28-19; 8:45 am]
 BILLING CODE 5001-06-P